Acute Pain Clinical Trial
Official title:
Opioid Prescription for Patient With Acute Pain After Discharge From Emergency Department: Ideal Duration for Adequate Relief, Adverse Events, and Addiction
Pain is one of the most common complaints in emergency department (ED) and is still often
poorly managed. A major prospective multicenter study reported that 74% of patients that had
a pain complaint at ED triage are discharged in moderate to severe pain. Accordingly,
physicians frequently prescribed analgesic after discharged for these patients, and opioid is
given in 29% of ED visits involving pain complaints. However, few studies evaluate pain
management after ED discharge: the frequency and length of opioids prescriptions, the opioids
quantity taken by the patients, are the patients relieved and satisfied by these pain
treatments, what are the adverse effects associated with the use of these medications, and
what are the chances of developing addiction?
The primary aim of this study is to determine the required minimal opioids prescription for
patients treated for acute pain after being discharge from the ED. Secondary objectives
include: 1) monitor the patients' adverse events during opioids treatment; 2) evaluate the
patients' level of pain relief associated with their respective opioids treatment; 3)
determine the patients' level of addiction following post-ED opioids treatments.
The design of the project is a prospective observational cohort study. A cohort of
consecutive ED patients aged 18 or more with an initial pain at triage of 4 or more and
discharged from the ED in less than 48 hours with a prescription of opioid will be asked to
participate in the study. Patients will be excluded if there is ongoing treatment for a
pre-existing chronic pain condition or if they used opioid drugs in the past year. Research
nurses will contact the patients by phone at three follow-up time points (1 week, 1 month,
and 3 months). Follow-up phone interviews will evaluate pain intensity as well as pain
treatment satisfaction (0-10 NRS), monitor adverse events, and investigate possible opioids
addiction (SOWS: subjective opioid withdrawal scale). During these interviews, the nurses
will also question the patients about their daily opioids usage and if they were relieved
from pain.
This study will provide the base for future guidelines regarding the prescription of opioids
treatment for specific pathology encountered in ED. It will also give indications on how to
adjust the treatments according to adverse events and the level of addiction experienced by
patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT03825549 -
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
|
N/A | |
Completed |
NCT05995912 -
Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain
|
Phase 2 | |
Recruiting |
NCT05589246 -
Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure
|
N/A | |
Recruiting |
NCT05572190 -
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
|
Phase 1 | |
Terminated |
NCT04716413 -
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
|
Phase 4 | |
Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
Not yet recruiting |
NCT06317844 -
Examination of Psychological and Physiological Pathways Linking Gratitude and Pain
|
N/A | |
Withdrawn |
NCT02957097 -
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
|
Phase 4 | |
Terminated |
NCT02599870 -
Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures
|
N/A | |
Completed |
NCT02565342 -
Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery
|
Phase 4 | |
Completed |
NCT02380989 -
Integrative Ayurveda Healing Relieves Minor Sports Injury Pain
|
Phase 2 | |
Completed |
NCT02984098 -
40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose
|
Phase 4 | |
Completed |
NCT02489630 -
Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department
|
Phase 4 | |
Completed |
NCT03107338 -
Preventive Treatment of Pain After Dental Implant Surgery
|
Phase 4 | |
Completed |
NCT02817477 -
Intranasal Ketamine for Acute Traumatic Pain
|
Phase 4 |